-
Advertisement
Junqiao Chen

Junqiao Chen

Junqiao Chen is a healthcare system partner at Roche, one of the world’s largest biotech companies and one of the earliest to operate in China. He has worked in various healthcare sectors in the US and Asia for almost a decade, with experience in real-world clinical research, value-based care and digital health. He is a published author in health policy, quality, and informatics in international academic journals and Hong Kong media outlets.
Junqiao Chen is a healthcare system partner at Roche, one of the world’s largest biotech companies and one of the earliest to operate in China. He has worked in various healthcare sectors in the US and Asia for almost a decade, with experience in real-world clinical research, value-based care and digital health. He is a published author in health policy, quality, and informatics in international academic journals and Hong Kong media outlets.
Languages Spoken:
English

Opinion | Learn from Covid-19 era to bolster Hong Kong’s healthcare sector

It might be tempting to relax after the easing of Hong Kong’s anti-pandemic measures, but the flu outbreak in China shows we must remain vigilant. This is a chance to set good practices to prepare for future pandemics, strengthen our healthcare system and establish the city as a biomedical innovation hub.

videocam

A pro-innovation healthcare system and favourable business environment could persuade multinational biotech companies to put more resources into Hong Kong. Collaboration is paramount and the Greater Bay Area should aim to be a pioneer in China.

Related Topic
Hong Kong healthcare and hospitals